Company intelligence / Profile preview

Ligno Biotech

Ownership: Private
Development stage: Other

Overview

Ligno Biotech is recognized for pioneering the successful commercial cultivation of Tiger Milk Mushroom and other functional mushrooms. The company leverages proprietary biotechnology for large-scale production, supplying ingredients for health supplements and related products.

Modalities: Live biotherapeutic product therapy (functional mushrooms)Microbial therapy (by extension from functional mushroom cultivation)
Industry: Non-Drug Biotech

Partnerships

Three industry partners mentioned but not named

Beyond the preview

Go deeper on Ligno Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ligno Biotech.

Explore the full profile